Evaluation of fitting models for prostate tissue characterization using extended‐range b‐factor diffusion‐weighted imaging by Langkilde, Fredrik, Kobus, Thiele, Fedorov, Andriy, Dunne, Ruth, Tempany, Clare, Mulkern, Robert V., Maier, Stephan E.

Get full text

Truly reproducible uniform estimation of the ADC with multi‐b diffusion data— Application in prostate diffusion imaging by Kuczera, Stefan, Langkilde, Fredrik, Maier, Stephan E.

Get full text

Optimized bias and signal inference in diffusion‐weighted image analysis (OBSIDIAN) by Kuczera, Stefan, Alipoor, Mohammad, Langkilde, Fredrik, Maier, Stephan E.

Get full text

Manual prostate MRI segmentation by readers with different experience: a study of the learning progress by Langkilde, Fredrik, Masaba, Patrick, Edenbrandt, Lars, Gren, Magnus, Halil, Airin, Hellström, Mikael, Larsson, Måns, Naeem, Ameer Ali, Wallström, Jonas, Maier, Stephan E., Jäderling, Fredrik

Get full text

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter? by Maier, Stephan E., Wallström, Jonas, Langkilde, Fredrik, Johansson, Jens, Kuczera, Stefan, Hugosson, Jonas, Hellström, Mikael

Get full text

Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study by Twilt, Jasper J, van Ginneken, Bram, Padhani, Anwar R, Bonekamp, David, Villeirs, Geert, Kalpathy-Cramer, Jayashree, van den Bergh, Roderick, Panebianco, Valeria, Kasivisvanathan, Veeru, Elschot, Mattijs, Veltman, Jeroen, Fütterer, Jurgen J, de Rooij, Maarten, Huisman, Henkjan, Saha, Anindo, Bosma, Joeran S., Twilt, Jasper J., van Ginneken, Bram, Slootweg, Ivan, Roest, Christian, Sunoqrot, Mohammed R.S., Bathen, Tone F., Rouw, Dennis, Geerdink, Jeroen, van Run, Chris, Groeneveld, Miriam, Meakin, James, Routier, Alexandre, Marcoux, Arnaud, Li, Cynthia Xinran, Feng, Dagan, Alis, Deniz, Karaarslan, Ercan, Ahn, Euijoon, Sonn, Geoffrey A., Bhattacharya, Indrani, Jahanandish, Hassan, An, Hong, Oksuz, Ilkay, Khadra, Mohamed, Şeker, Mustafa E., Kartal, Mustafa S., Debs, Noëlie, Fan, Richard E., Saunders, Sara, Soerensen, Simon J.C., Vesal, Sulaiman, Kawashima, Akira, Moreira, Ana Sofia L., Rappaport, Annelies, Stanzione, Arnaldo, Ciuvasovas, Arturas, Pedersen, Bodil G., Eijlers, Bram, Chen, Christine, Aringhieri, Giacomo, Brembilla, Giorgio, Son, Hannah, Vanderlelij, Hans, Raat, Henricus P.J., Pikūnienė, Ingrida, Schoots, Ivo, Zawaideh, Jeries P., Wallström, Jonas, Bittencourt, Leonardo K., Khurram, Misbah, Choi, Moon H., Takahashi, Naoki, Tan, Nelly, Franco, Paolo N., Gutierrez, Patricia A., Thimansson, Per Erik, Hanus, Pieter, Puech, Philippe, Rau, Philipp R., de Visschere, Pieter, Falcão, Ricardo O., van Stiphout, Rogier S.A., Briediene, Ruta, Gitau, Samuel, Withey, Samuel, Ghai, Sangeet, Penzkofer, Tobias, Barrett, Tristan, Tammisetti, Varaha S., Løgager, Vibeke B., Černý, Vladimír, Bonekamp, David, Villeirs, Geert, Giannarini, Gianluca, Kalpathy-Cramer, Jayashree, Maier-Hein, Klaus H., Obuchowski, Nancy A., Rouvière, Olivier, van den Bergh, Roderick, Panebianco, Valeria, Kasivisvanathan, Veeru, Veltman, Jeroen, Fütterer, Jurgen J., de Rooij, Maarten

Get full text

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial by Solomon, Scott D., Boer, Rudolf A., DeMets, David, Hernandez, Adrian F., Inzucchi, Silvio E., Kosiborod, Mikhail N., Lam, Carolyn S.P., Martinez, Felipe, Shah, Sanjiv J., Lindholm, Daniel, Wilderäng, Ulrica, Öhrn, Fredrik, Claggett, Brian, Langkilde, Anna Maria, Petersson, Magnus, McMurray, John J.V.

Get full text

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical... by Araki, Eiichi, Watada, Hirotaka, Uchigata, Yasuko, Tomonaga, Osamu, Fujii, Hitomi, Ohashi, Hiroshi, Okabe, Tadashi, Asano, Michiko, Thoren, Fredrik, Kim, Hyosung, Yajima, Toshitaka, Langkilde, Anna Maria

Get full text

SAT-LB025 Analysis of Benefit/Risk in the Subgroup of Patients with BMI of >=27 Kg/m2 in the Dapagliflozin DEPICT-1 and -2 Trials in Type 1 Diabetes by Mathieu, Chantal, Dandona, Paresh, Phillip, Moshe, Xu, John, Thorén, Fredrik, Scheerer, Markus, Langkilde, Anna-Maria

Get full text